Purdue Urges Appeals Court to Revive Sackler Opioid Lawsuit Shield

Purdue Urges Appeals Court to Revive Sackler Opioid Lawsuit Shield
Bottles of prescription painkiller OxyContin, 40mg pills, made by Purdue Pharma L.D. sit on a shelf at a local pharmacy, in Provo, Utah, on April 25, 2017. George Frey/Reuters
|Updated:

Judges on a U.S. appeals court appeared hesitant on Friday to revive a legal shield that would protect members of the Sackler family who own Purdue Pharma from lawsuits related to the prescription opioid OxyContin, a key to ending the company’s bankruptcy.

During oral arguments, a three-judge panel on the 2nd U.S. Circuit Court of Appeals probed the limits of a bankruptcy judge’s authority to protect non-bankrupt parties like the wealthy Sacklers.